Literature DB >> 11496128

Inhibition of myopia development in chicks using himbacine: a role for M(4) receptors?

C L Cottriall1, H T Truong, N A McBrien.   

Abstract

The success of the M(1)-selective muscarinic antagonist pirenzepine in preventing myopia development in animal models implicates a role for the M(1) receptor. However, the relatively high dose of pirenzepine required may indicate that the drug acts through another receptor subtype. This study examined whether the M(4)-selective antagonist, himbacine, could also prevent myopia. Daily intravitreal injections of himbacine inhibited the inducement of myopia in chick eyes in a dose- dependent manner. Doses < or = 200 microg caused no significant inhibition of induced myopia compared to controls (-13.7 +/- 2.3 vs -16.2 +/- 0.9D, ANOVA p = 0.37), whilst a dose of 800 microg almost completely inhibited the induced myopia (-2.4 +/- 2.0, p < 0.01). Findings demonstrate himbacine is effective at preventing the development of myopia in chick and implicates a role for the M4 receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496128     DOI: 10.1097/00001756-200108080-00033

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

Review 1.  RPE and Choroid Mechanisms Underlying Ocular Growth and Myopia.

Authors:  Yan Zhang; Christine F Wildsoet
Journal:  Prog Mol Biol Transl Sci       Date:  2015-07-23       Impact factor: 3.622

Review 2.  IMI - Report on Experimental Models of Emmetropization and Myopia.

Authors:  David Troilo; Earl L Smith; Debora L Nickla; Regan Ashby; Andrei V Tkatchenko; Lisa A Ostrin; Timothy J Gawne; Machelle T Pardue; Jody A Summers; Chea-Su Kee; Falk Schroedl; Siegfried Wahl; Lyndon Jones
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-28       Impact factor: 4.799

3.  Opposing effects of atropine and timolol on the color and luminance emmetropization mechanisms in chicks.

Authors:  Laura A Goldberg; Frances J Rucker
Journal:  Vision Res       Date:  2016-03-19       Impact factor: 1.886

Review 4.  Pharmacology of myopia and potential role for intrinsic retinal circadian rhythms.

Authors:  Richard A Stone; Machelle T Pardue; P Michael Iuvone; Tejvir S Khurana
Journal:  Exp Eye Res       Date:  2013-01-08       Impact factor: 3.467

Review 5.  Pharmacogenomic Approach to Antimyopia Drug Development: Pathways Lead the Way.

Authors:  Tatiana V Tkatchenko; Andrei V Tkatchenko
Journal:  Trends Pharmacol Sci       Date:  2019-10-30       Impact factor: 14.819

6.  Expression of muscarinic receptor subtypes in tree shrew ocular tissues and their regulation during the development of myopia.

Authors:  N A McBrien; A I Jobling; H T Truong; C L Cottriall; A Gentle
Journal:  Mol Vis       Date:  2009-03-02       Impact factor: 2.367

7.  Overnight orthokeratology is comparable with atropine in controlling myopia.

Authors:  Hui-Ju Lin; Lei Wan; Fuu-Jen Tsai; Yi-Yu Tsai; Liuh-An Chen; Alicia Lishin Tsai; Yu-Chuen Huang
Journal:  BMC Ophthalmol       Date:  2014-03-31       Impact factor: 2.209

8.  Muscarinic acetylcholine receptor 1 gene polymorphisms associated with high myopia.

Authors:  Hui-Ju Lin; Lei Wan; Yuhsin Tsai; Wen-Chi Chen; Shih-Wei Tsai; Fuu-Jen Tsai
Journal:  Mol Vis       Date:  2009-09-04       Impact factor: 2.367

Review 9.  Muscarinic Acetylcholine Receptors in the Retina-Therapeutic Implications.

Authors:  Yue Ruan; Andreas Patzak; Norbert Pfeiffer; Adrian Gericke
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

10.  Muscarinic cholinergic receptor (M2) plays a crucial role in the development of myopia in mice.

Authors:  Veluchamy A Barathi; Jia Lin Kwan; Queenie S W Tan; Sung Rhan Weon; Li Fong Seet; Liang Kee Goh; Eranga N Vithana; Roger W Beuerman
Journal:  Dis Model Mech       Date:  2013-05-02       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.